Form D · Biotechnology
Rapalogix Health, Inc.
Carlsbad, CA · CIK 0002008372
Offering snapshot reported Jun 26, 2026 · SEC filing
- Reported sold
- $19.1M Offering amount: $25M
- Investors reported
- 28 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 22, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 26, 2026 | Initial | $19,112,746 | No comparison | 28 | SEC filing |
| Jun 4, 2025 | Amendment | $9,079,616 | $1,079,616vs Jan 17, 2024 | 24 | SEC filing |
| Jan 17, 2024 | Initial | $8,000,000 | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-588703
Source: Form D, filed Jun 26, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Doris Day | Director |
| Neetu Dhaliwal | Director |
| Craig Gordon | Director |
| Juliette Han | Director |
| Joan Mannick | Director |
| Rahul Mehta | Executive |
| David Nicholson | Director |
| James Peyer | Director |
| Brent Saunders | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3129 Tiger Run Court Suite 207
Carlsbad, CA, 92010
Phone: (760) 707-2412
Carlsbad, CA, 92010
Phone: (760) 707-2412